Announcement of CGU's 2022-2023 Highly Cited Papers Listed in the Essential Science Indicators (ESI)

Clarivate’s Essential Science Indicators (ESI) database regularly selects the top 1% of articles with the highest citation counts in each field over the past 10 years as Highly Cited Papers. (For details on the selection mechanism for Highly Cited Papers, please refer to: https://webofscience.help.clarivate.com/zh-tw/Content/esi-highly-cited-papers.html)

Being recognized as a Highly Cited Paper is no easy feat. To honor the outstanding achievements in publications and the research impact of our full-time faculty and researchers, the Office of Research and Development will annually announce, at the end of each year, the Highly Cited Papers published under the university’s name by first or corresponding authors over the past two years (excluding the current year).

List of Papers:

A. Kuo-Hsuan Chang, School of Medicine (Corresponding author)
Biomarker of Neuroinflammation in Parkinson's Disease (Int J Mol Sci 2022;23:4148)

B. Jui-Yang Lai, Department of Biomedical Engineering (Corresponding author)
Poly(l-Histidine)-Mediated On-Demand Therapeutic Delivery of Roughened Ceria Nanocages for Treatment of Chemical Eye Injury (Adv Sci 2023;10:e2302174)

C. Meng Lee, School of Medicine (First author)
Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention: A Meta-analysis of Randomized Clinical Trials (JAMA Neurol 2022;79:349-358)

D. Wen-Juei Jeng, School of Medicine (First author)
Hepatitis B (Lancet 2023;401:1039-1052)

E. Chao-Ying Chen, School of Physical Therapy and Graduate Institute of Rehabilitation Science (First author)
Exploring mediational roles for self-stigma in associations between types of problematic use of internet and psychological distress in youth with ADHD (Res Dev Disabil 2023;133:104410)


Contact person:Fen-Ping Hsu
Contact number:413-5268